Institutions / Resolute Capital Asset Partners LLC

Resolute Capital Asset Partners LLC

CIK 1834913 · Institution · as of Dec 31, 2025

Portfolio value

$206.98M

Positions

As of

Dec 31, 2025

Top holdings

Dec 31, 2025View all 49 →

Company	Class	Value	Shares	% of portfolio
Ascendis Pharma A/S	—	$18.90M	88,627	9.1%
Amazon.com Inc	—	$16.42M	71,158	7.9%
Andersons, Inc.	—	$13.82M	260,000	6.7%
Texas Pacific Land Corp	—	$13.07M	45,500	6.3%
Alphabet Inc.	—	$9.41M	30,000	4.5%
Abivax Sa	—	$8.77M	65,000	4.2%
Cidara Therapeutics Inc	—	$8.24M	37,315	4.0%
Jazz Pharmaceuticals PLC	—	$6.80M	40,000	3.3%
Madrigal Pharmaceuticals, Inc.	—	$6.36M	10,918	3.1%
Thermo Fisher Scientific Inc.	—	$5.79M	10,000	2.8%
Crane Co	—	$5.53M	30,000	2.7%
Schwab Charles Corp	—	$5.50M	55,000	2.7%
Synopsys Inc	—	$4.70M	10,000	2.3%
Danaher Corp /De	—	$4.58M	20,000	2.2%
Glaukos Corp	—	$4.57M	40,500	2.2%
Bunge Global SA	—	$4.45M	50,000	2.2%
APi Group Corp	—	$4.40M	115,000	2.1%
Aar Corp	—	$4.14M	50,000	2.0%
Cytokinetics Inc	—	$4.13M	65,000	2.0%
NRG Energy Inc	—	$3.98M	25,000	1.9%
Amrize Ltd	—	$3.79M	70,000	1.8%
Autozone Inc	—	$3.73M	1,100	1.8%
Kirby Corp	—	$3.31M	30,000	1.6%
Vistra Corp.	—	$3.23M	20,000	1.6%
Carpenter Technology Corp	—	$3.15M	10,000	1.5%

Activity

Dec 31, 2025

InsidersInstitutions

This fund's 13F position changes — what it's buying and selling.

No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.